Post-operative radioactive iodine administration in patients with low-risk thyroid cancer

被引：0
|
作者：
Sophie Leboulleux
Isabelle Borget
Martin Schlumberger
机构：
[1] Geneva University Hospitals,Division of Endocrinology, Diabetes, Nutrition and Therapeutic patient education
[2] Paris-Saclay University,Biostatistics and Epidemiology office, Gustave Roussy
[3] Paris-Saclay University,Oncostat
[4] Paris-Saclay University,Ligue Contre le Cancer labelled team, Inserm
[5] Paris-Saclay University,Nuclear Medicine and Endocrine Oncology, Gustave Roussy
来源：
Nature Reviews Endocrinology | 2022年 / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Radioactive iodine (RAI) treatment is used in patients with thyroid cancer to treat disease and to eradicate normal thyroid remnants. Routine post-operative administration of RAI is no longer indicated in patients with low risk thyroid cancer and might instead be used selectively in patients with a post-operative high serum level of thyroglobulin.
引用
收藏
页码：585 / 586
页数：1
相关论文
共 50 条
  • [1] Post-operative radioactive iodine administration in patients with low-risk thyroid cancer
    Leboulleux, Sophie
    Borget, Isabelle
    Schlumberger, Martin
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2022, 18 (10) : 585 - 586
  • [2] The overuse of radioactive iodine in low-risk papillary thyroid cancer patients
    Moten, Ambria S.
    Zhao, Huaqing
    Willis, Alliric, I
    [J]. SURGICAL ONCOLOGY-OXFORD, 2019, 29 : 184 - 189
  • [3] Radioactive iodine ablation in low-risk thyroid cancer
    Hindie, Elif
    Taieeb, David
    Avram, Anca M.
    Giovanella, Luca
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (09): : 686 - 686
  • [4] Low-risk Thyroid Cancer, Surgical Training, and Radioactive Iodine
    Ashok R. Shaha
    [J]. Annals of Surgical Oncology, 2013, 20 : 703 - 704
  • [5] Low-risk Thyroid Cancer, Surgical Training, and Radioactive Iodine
    Shaha, Ashok R.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (03) : 703 - 704
  • [6] Well-differentiated thyroid carcinoma: The role of post-operative radioactive iodine administration
    Patel, Supriya S.
    Goldfarb, Melanie
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (06) : 665 - 672
  • [7] Impact on Overall Survival of Radioactive Iodine in Low-Risk Differentiated Thyroid Cancer Patients
    Schvartz, Claire
    Bonnetain, Franck
    Dabakuyo, Sandrine
    Gauthier, Melanie
    Cueff, Adele
    Fieffe, Sandrine
    Pochart, Jean-Marie
    Cochet, Inna
    Crevisy, Elodie
    Dalac, Audrey
    Papathanassiou, Dimitri
    Toubeau, Michel
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (05): : 1526 - 1535
  • [8] Outcomes of ATA Low-Risk Pediatric Thyroid Cancer Patients Not Treated With Radioactive Iodine Therapy
    Bojarsky, Mya
    Baran, Julia A.
    Halada, Stephen
    Isaza, Amber
    Zhuang, Hongming
    States, Lisa
    Grant, Frederick D.
    Robbins, Stephanie
    Sisko, Lindsay
    Ricarte-Filho, Julio C.
    Kazahaya, Ken
    Adzick, N. Scott
    Mostoufi-Moab, Sogol
    Bauer, Andrew J.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (12): : 3338 - 3344
  • [9] The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer
    Haymart, Megan R.
    Banerjee, Mousumi
    Yang, Di
    Stewart, Andrew K.
    Koenig, Ronald J.
    Griggs, Jennifer J.
    [J]. CANCER, 2013, 119 (02) : 259 - 265
  • [10] Early Post-operative Stimulated Serum Thyroglobulin: Role in Preventing Unnecessary Radioactive Iodine Treatment in Low to Intermediate Risk Papillary Thyroid Cancer
    Sezer, Havva
    Yazici, Dilek
    Terzioglu, Tarik
    Tezelman, Serdar
    Canbaz, Hande Bulut
    Yerlikaya, Aslihan
    Demirkol, Mehmet Onur
    Kapran, Yersu
    Colakoglu, Bulent
    Cilingiroglu, Eda Nur
    Alagol, Faruk
    [J]. AMERICAN SURGEON, 2023, 89 (12) : 5996 - 6004
12345